{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:29:47Z","timestamp":1780633787512,"version":"3.54.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,7]],"date-time":"2015-05-07T00:00:00Z","timestamp":1430956800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.ijid.2015.05.006","type":"journal-article","created":{"date-parts":[[2015,5,21]],"date-time":"2015-05-21T10:12:01Z","timestamp":1432203121000},"page":"46-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Impact of tuberculosis treatment and antiretroviral therapy on serial RD-1-specific quantitative T-cell readouts (QuantiFERON-TB Gold In-Tube), and relationship to treatment-related outcomes and bacterial burden"],"prefix":"10.1016","volume":"36","author":[{"given":"Thuli","family":"Mthiyane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Rustomjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Pym","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Onyebujoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Theron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keertan","family":"Dheda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2015.05.006_bib0325","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0140-6736(02)09742-8","article-title":"Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial","volume":"360","author":"Benator","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2015.05.006_bib0330","first-page":"290","article-title":"Challenges in tuberculosis drug research and development","volume":"13","author":"Ginsberg","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2015.05.006_bib0335","first-page":"241","article-title":"Timing of relapse in short-course chemotherapy trials for tuberculosis","volume":"14","author":"Nunn","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2015.05.006_bib0340","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/S0140-6736(07)60284-0","article-title":"Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes","volume":"369","author":"Getahun","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2015.05.006_bib0345","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1473-3099(10)70071-2","article-title":"Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis","volume":"10","author":"Horne","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2015.05.006_bib0350","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1471-2334-7-122","article-title":"Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia","volume":"7","author":"Adetifa","year":"2007","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2015.05.006_bib0355","doi-asserted-by":"crossref","unstructured":"Adetifa IM, Ota MO, Jeffries DJ, Hammond A, Lugos MD, Donkor S, et al. Commercial interferon gamma release assays compared to the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection in childhood contacts in the Gambia. Pediatr Infect Dis J 2010.","DOI":"10.1097\/INF.0b013e3181cb45da"},{"key":"10.1016\/j.ijid.2015.05.006_bib0360","doi-asserted-by":"crossref","first-page":"e12502","DOI":"10.1371\/journal.pone.0012502","article-title":"Decay kinetics of an interferon gamma release assay with anti-tuberculosis therapy in newly diagnosed tuberculosis cases","volume":"5","author":"Adetifa","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2015.05.006_bib0365","doi-asserted-by":"crossref","first-page":"149","DOI":"10.7883\/yoken.JJID.2009.149","article-title":"The evaluation of the Quantiferon-TB Gold test in pulmonary and extrapulmonary tuberculosis","volume":"62","author":"Ak","year":"2009","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.ijid.2015.05.006_bib0370","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ijid.2008.03.026","article-title":"Interferon-gamma release assays (IGRAs) in high-endemic settings: could they play a role in optimizing global TB diagnostics? Evaluating the possibilities of using IGRAs to diagnose active TB in a rural African setting","volume":"12","author":"Barth","year":"2008","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2015.05.006_bib0375","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.rmed.2010.05.011","article-title":"Limited usefulness of QuantiFERON-TB Gold In-Tube\u00ae for monitoring anti-tuberculosis therapy","volume":"104","author":"Bocchino","year":"2010","journal-title":"Respir Med"},{"issue":"6","key":"10.1016\/j.ijid.2015.05.006_bib0380","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s10096-008-0670-8","article-title":"Quantitative T-cell interferon-gamma responses to Mycobacterium tuberculosis-specific antigens in active and latent tuberculosis","volume":"28","author":"Chee","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijid.2015.05.006_bib0385","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2334-10-138","article-title":"Reversion and conversion of Mycobacterium tuberculosis IFN-\u03b3 ELISpot results during anti-tuberculous treatment in HIV-infected children","volume":"10","author":"Connell","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2015.05.006_bib0390","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/MCP.0b013e32832a0adc","article-title":"T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings","volume":"15","author":"Dheda","year":"2009","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.ijid.2015.05.006_bib0395","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1183\/09031936.00005309","article-title":"Utility of quantitative T-cell responses versus unstimulated interferon-{gamma} for the diagnosis of pleural tuberculosis","volume":"34","author":"Dheda","year":"2009","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.ijid.2015.05.006_bib0400","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/427030","article-title":"Qantitative T cell assay reflects infectious load of mycobactirium tuberculosis in an endemic case contact model","author":"Hill","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2015.05.006_bib0405","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3233\/JPI-2010-0236","article-title":"Yield of QuantiFERON-TB gold in tube assay and tuberculin skin test in healthy persons from a tuberculosis endemic population","volume":"5","author":"Kabeer","year":"2010","journal-title":"J Pediatr Infect Dis"},{"key":"10.1016\/j.ijid.2015.05.006_bib0410","first-page":"1146","article-title":"Use of the QuantiFERON-TB Gold In-Tube test to monitor treatment efficacy in active pulmonary tuberculosis","volume":"12","author":"Katiyar","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2015.05.006_bib0415","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jinf.2008.08.009","article-title":"Transitional changes in T-cell responses to Mycobacterium tuberculosis-specific antigens during treatment","volume":"58","author":"Kobashi","year":"2009","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2015.05.006_bib0420","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.2169\/internalmedicine.47.1313","article-title":"Long-term follow-up of the QuantiFERON TB-2G test for active tuberculosis disease","volume":"47","author":"Kobashi","year":"2008","journal-title":"Intern Med"},{"key":"10.1016\/j.ijid.2015.05.006_bib0425","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.rmed.2009.10.006","article-title":"Serial interferon-gamma release assays after rifampicin prophylaxis in a tuberculosis outbreak","volume":"104","author":"Lee","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.ijid.2015.05.006_bib0430","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s15010-007-6114-z","article-title":"Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis treatment","volume":"35","author":"Pai","year":"2007","journal-title":"Infection"},{"key":"10.1016\/j.ijid.2015.05.006_bib0435","doi-asserted-by":"crossref","first-page":"e5187","DOI":"10.1371\/journal.pone.0005187","article-title":"In vivo and in vitro effects of antituberculosis treatment on mycobacterial interferon-gamma T cell response","volume":"4","author":"Sauzullo","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2015.05.006_bib0440","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1371\/journal.pone.0037436","article-title":"Correlation of Mycobacterium tuberculosis specific and non-specific quantitative Th1 T-cell responses with bacillary load in a high burden setting","volume":"7","author":"Theron","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2015.05.006_bib0445","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2334-11-135","article-title":"IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy","volume":"11","author":"Kabeer","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2015.05.006_bib0450","first-page":"215","article-title":"The effect of antituberculosis treatment on interferon-gamma release assay results","volume":"75","author":"Bugiani","year":"2011","journal-title":"Monaldi Arch Chest Dis"},{"key":"10.1016\/j.ijid.2015.05.006_bib0455","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1371\/journal.pmed.0040192","article-title":"Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection","volume":"4","author":"Hill","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijid.2015.05.006_bib0460","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1183\/09059180.00010816","article-title":"Monitoring the efficacy of anti-TB therapy by using the QuantiFERON-TB Gold In tube test","volume":"17","author":"Markova","year":"2008","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.ijid.2015.05.006_bib0465","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1183\/09031936.00151309","article-title":"Tuberculosis treatment effect on T-cell interferon-\u03b3 responses to Mycobacterium tuberculosis-specific antigens","volume":"36","author":"Chee","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2015.05.006_bib0470","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2334-10-57","article-title":"Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country","volume":"10","author":"Dyrhol-Riise","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"10","key":"10.1016\/j.ijid.2015.05.006_bib0475","doi-asserted-by":"crossref","first-page":"e26787","DOI":"10.1371\/journal.pone.0026787","article-title":"Longitudinal analysis of QuantiFERON-TBGold In-Tube in children with adult household tuberculosis contact in South Africa: a prospective cohort study","volume":"6","author":"Shah","year":"2011","journal-title":"PloS ONE"},{"key":"10.1016\/j.ijid.2015.05.006_bib0480","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2334-11-135","article-title":"IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy","volume":"11","author":"Kabeer","year":"2011","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2015.05.006_bib0485","doi-asserted-by":"crossref","first-page":"133","DOI":"10.7883\/yoken.64.133","article-title":"Analysis of an interferon-gamma release assay for monitoring the efficacy of anti-tuberculosis chemotherapy","volume":"64","author":"Takayanagi","year":"2011","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.ijid.2015.05.006_bib0490","doi-asserted-by":"crossref","first-page":"e4130","DOI":"10.1371\/journal.pone.0004130","article-title":"Temporal dynamics of interferon gamma responses in children evaluated for tuberculosis","volume":"4","author":"Herrmann","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2015.05.006_bib0495","first-page":"8","article-title":"Serial T-SPOT.TB and Quantiferon-TB-Gold In Tube assays to monitor response to anti-tubercular treatment in Italian children with active or latent tuberculosis Infection","volume":"8","author":"Chiappini","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijid.2015.05.006_bib0500","doi-asserted-by":"crossref","first-page":"e2624","DOI":"10.1371\/journal.pone.0002624","article-title":"A three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT.TB in children","volume":"3","author":"Connell","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2015.05.006_bib0505","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2334-6-66","article-title":"Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases","volume":"6","author":"Aiken","year":"2006","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2015.05.006_bib0510","first-page":"818","article-title":"Sputum cytokine levels in patients with pulmonary tuberculosis as early markers of mycobacterial clearance","volume":"9","author":"Ribeiro-Rodrigues","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.ijid.2015.05.006_bib0515","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.4049\/jimmunol.167.9.5217","article-title":"Direct ex vivo analysis of antigen-specific IFN-\u03b3-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment","volume":"167","author":"Pathan","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.ijid.2015.05.006_bib0520","doi-asserted-by":"crossref","first-page":"e37436","DOI":"10.1371\/journal.pone.0037436","article-title":"Correlation of Mycobacterium tuberculosis specific and non-specific quantitative Th1 T-cell responses with bacillary load in a high burden setting","volume":"7","author":"Theron","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2015.05.006_bib0525","unstructured":"World Health Organization. Global tuberculosis report 2012. WHO\/HTM\/TB\/2012.6. WHO; 2012."},{"key":"10.1016\/j.ijid.2015.05.006_bib0530","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1128\/AAC.05526-11","article-title":"Reduced antituberculosis drug concentrations in HIV-infected patients who are men or have low weight: implications for international dosing guidelines","volume":"56","author":"McIlleron","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2015.05.006_bib0535","series-title":"Tuberculosis: pathogenesis, protection, and control","first-page":"85","article-title":"Current laboratory methods for the diagnosis of tuberculosis","author":"Heifets","year":"1994"},{"key":"10.1016\/j.ijid.2015.05.006_bib0540","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.200402-179OC","article-title":"Specific detection of tuberculosis infection","volume":"170","author":"Mori","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijid.2015.05.006_bib0545","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1164\/rccm.200811-1704OC","article-title":"Within-subject variability and boosting of T-cell interferon-\u03b3 responses after tuberculin skin testing","volume":"180","author":"van Zyl-Smit","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijid.2015.05.006_bib0550","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1183\/09031936.00171509","article-title":"Enhanced diagnosis of HIV-1-associated tuberculosis by relating T-SPOT.TB and CD4 counts","volume":"36","author":"Oni","year":"2010","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.ijid.2015.05.006_bib0555","first-page":"754","article-title":"Interferon-gamma release assay for treatment monitoring of active tuberculosis\u2014an explosion in the spaghetti factory","volume":"38","author":"Denkinger","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2015.05.006_bib0560","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1086\/381754","article-title":"Use of a T cell\u2013based assay for monitoring efficacy of antituberculosis therapy","volume":"38","author":"Carrara","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2015.05.006_bib0565","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1440-1843.2010.01739.x","article-title":"The immunology of tuberculosis: from bench to bedside","volume":"15","author":"Dheda","year":"2010","journal-title":"Respirology"},{"issue":"11","key":"10.1016\/j.ijid.2015.05.006_bib0585","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1164\/rccm.201210-1934OC","article-title":"Regulatory T-cells attenuate mycobacterial stasis in alveolar and blood derived macrophages from patients with TB","volume":"187","author":"Semple","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijid.2015.05.006_bib0590","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1164\/rccm.201006-0963PP","article-title":"Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection","volume":"183","author":"Schwander","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijid.2015.05.006_bib0595","doi-asserted-by":"crossref","first-page":"512","DOI":"10.7196\/SAMJ.5358","article-title":"Immunological characterisation of an unmasking TB-IRIS case","volume":"102","author":"Wilkinson","year":"2012","journal-title":"S Afr Med J"},{"key":"10.1016\/j.ijid.2015.05.006_bib0600","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1164\/rccm.201008-1246CI","article-title":"Novel developments in the epidemic of human immunodeficiency virus and tuberculosis coinfection","volume":"183","author":"Anandaiah","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijid.2015.05.006_bib0605","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1097\/00002030-200209270-00021","article-title":"High incidence of tuberculin skin test conversion among HIV-infected individuals who have a favourable immunological response to highly active antiretroviral therapy","volume":"16","author":"Girardi","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2015.05.006_bib0610","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/01.aids.0000176211.08581.5a","article-title":"How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control","volume":"19","author":"Lawn","year":"2005","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.ijid.2015.05.006_bib0615","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000171.pub3","article-title":"Treatment of latent tuberculosis infection in HIV infected persons","volume":"20","author":"Akolo","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijid.2015.05.006_bib0620","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/S0140-6736(11)60204-3","article-title":"6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial","volume":"377","author":"Samandari","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2015.05.006_bib0640","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1473-3099(09)70042-8","article-title":"Biomarkers for tuberculosis disease activity, cure, and relapse","volume":"9","author":"Wallis","year":"2009","journal-title":"Lancet Infect Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971215001137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971215001137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T19:37:08Z","timestamp":1691696228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971215001137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":58,"alternative-id":["S1201971215001137"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2015.05.006","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of tuberculosis treatment and antiretroviral therapy on serial RD-1-specific quantitative T-cell readouts (QuantiFERON-TB Gold In-Tube), and relationship to treatment-related outcomes and bacterial burden","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2015.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}